title: Genetic variation of the cutaneous HPA axis: an analysis of UVB-induced differential responses.
abstract: Mammalian skin incorporates a local equivalent of the hypothalamic-pituitary-adrenal (HPA) axis that is critical in coordinating homeostatic responses against external noxious stimuli. Ultraviolet radiation B (UVB) is a skin-specific stressor that can activate this cutaneous HPA axis. Since C57BL/6 (B6) and DBA/2J (D2) strains of mice have different predispositions to sensorineural pathway activation, we quantified expression of HPA axis components at the gene and protein levels in skin incubated ex vivo after UVB or sham irradiation. Urocortin mRNA was up-regulated after all doses of UVB with a maximum level at 50 mJ/cm(2) after 12h for D2 and at 200 mJ/cm(2) after 24h for B6. Proopiomelanocortin mRNA was enhanced after 6h with the peak after 12h and at 200 mJ/cm(2) for both genotypes of mice. ACTH levels in tissue and media increased after 24h in B6 but not in D2. UVB stimulated β-endorphin expression was higher in D2 than in B6. Melanocortin receptor 2 mRNA was stimulated by UVB in a dose-dependent manner, with a peak at 200 mJ/cm(2) after 12h for both strains. The expression of Cyp11a1 mRNA - a key mitochondrial P450 enzyme in steroidogenesis, was stimulated at all doses of UVB irradiation, with the most pronounced effect after 12-24h. UVB radiation caused, independently of genotype, a dose-dependent increase in corticosterone production in the skin, mainly after 24h of histoculture. Thus, basal and UVB stimulated expression of the cutaneous HPA axis differs as a function of genotype: D2 responds to UVB earlier and with higher amplitude than B6, while B6 shows prolonged (up to 48 h) stress response to a noxious stimulus such as UVB.
authors: Department of Pathology and Laboratory Medicine, Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Electronic address: cskobowi@uthsc.edu.
authors: Cezary
authors: C
authors: Skobowiat
authors: Reza
authors: R
authors: Nejati
authors: Lu
authors: L
authors: Lu
authors: Robert W
authors: RW
authors: Williams
authors: Andrzej T
authors: AT
authors: Slominski
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000096:biosynthesis; D000818:Animals; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000096:biosynthesis; D004307:Dose-Response Relationship, Radiation; D005786:Gene Expression Regulation / Q000528:radiation effects*; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D010913:Pituitary-Adrenal System / Q000378:metabolism*; D011333:Pro-Opiomelanocortin / Q000096:biosynthesis; D044103:Receptor, Melanocortin, Type 2 / Q000096:biosynthesis; D014466:Ultraviolet Rays; D054832:Urocortins / Q000096:biosynthesis; D001615:beta-Endorphin / Q000096:biosynthesis
chemical_list: D044103:Receptor, Melanocortin, Type 2; D054832:Urocortins; D001615:beta-Endorphin; D011333:Pro-Opiomelanocortin; D000324:Adrenocorticotropic Hormone; D002786:Cholesterol Side-Chain Cleavage Enzyme
keywords: ACTH; B6; C57BL/6J; C57Bl/6; COR; CORT; CRH; Cutaneous stress; D2; DBA/2J; DBA2J; GC; GR; HPA axis; POMC; UCN1; UVR; Ultraviolet B radiation; adrenocorticotropin; corticosterone; corticotropin releasing hormone; cortisol; glucocorticoid receptor; glucocorticoids; hypothalamic–pituitary–adrenal axis; proopiomelanocortin; ultraviolet radiation; urocortin; β-END; β-endorphin
references: Addict Biol. 2014 May;19(3):370-9
references: 23145527
references: J Invest Dermatol. 1993 Jul;101(1 Suppl):90S-97S
references: 8326158
references: J Invest Dermatol. 2011 Mar;131(3):613-22
references: 21191404
references: FEBS Lett. 1996 Dec 9;399(1-2):175-6
references: 8980146
references: FEBS Lett. 1999 Jul 23;455(3):364-6
references: 10437805
references: Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E701-6
references: 15572653
references: J Invest Dermatol. 1997 Feb;108(2):160-5
references: 9008228
references: Exp Dermatol. 1994 Feb;3(1):45-50
references: 8061934
references: Endocrinology. 2005 Mar;146(3):1245-53
references: 15564334
references: Ann N Y Acad Sci. 1999 Oct 20;885:448-50
references: 10816685
references: Int J Dermatol. 1996 Dec;35(12):849-51
references: 8970839
references: Endocrinology. 2012 Oct;153(10):4830-7
references: 22893724
references: Physiol Rev. 2004 Oct;84(4):1155-228
references: 15383650
references: Physiol Rev. 2000 Jul;80(3):979-1020
references: 10893429
references: J Invest Dermatol. 1999 Oct;113(4):523-32
references: 10504436
references: FASEB J. 2001 Aug;15(10):1678-93
references: 11481215
references: PLoS One. 2011 Apr 08;6(4):e18405
references: 21494628
references: Endocr Rev. 2013 Dec;34(6):827-84
references: 23939821
references: Int Rev Neurobiol. 2012;104:135-57
references: 23195314
references: Adv Anat Embryol Cell Biol. 2012;212:v, vii, 1-115
references: 22894052
references: J Clin Endocrinol Metab. 2000 Feb;85(2):815-23
references: 10690896
references: J Mol Endocrinol. 2009 Jun;42(6):479-89
references: 19318426
references: Am J Physiol Endocrinol Metab. 2011 Sep;301(3):E484-93
references: 21673307
references: Cell. 2012 Sep 14;150(6):1287-99
references: 22939713
references: J Neuroimmunol. 2005 May;162(1-2):97-102
references: 15833364
references: Eur J Biochem. 2004 Nov;271(21):4178-88
references: 15511223
references: Pigment Cell Res. 2003 Aug;16(4):333-44
references: 12859616
references: J Clin Endocrinol Metab. 1996 Jul;81(7):2746-9
references: 8675607
references: Exp Dermatol. 2009 May;18(5):424-30
references: 19382313
references: Mol Cell Endocrinol. 2007 Feb;265-266:143-9
references: 17197073
references: Biochem Biophys Res Commun. 2011 Jan 7;404(1):62-7
references: 21094146
references: Experientia. 1992 Jan 15;48(1):50-4
references: 1737578
references: Biochim Biophys Acta. 1998 Nov 19;1448(1):147-52
references: 9824688
references: J Neurosci Methods. 2010 Apr 30;188(1):62-70
references: 20149823
references: Biochim Biophys Acta. 1996 Mar 15;1289(2):247-51
references: 8600981
references: Ann N Y Acad Sci. 1999 Oct 20;885:100-16
references: 10816644
references: Mol Endocrinol. 2006 Oct;20(10):2539-47
references: 16740657
references: Endocrinology. 2004 Feb;145(2):941-50
references: 14605004
references: Physiol Rev. 2001 Jan;81(1):449-494
references: 11152763
references: J Biol Chem. 2011 Mar 25;286(12):10265-75
references: 21239489
references: FASEB J. 2005 Aug;19(10):1332-4
references: 15946990
references: J Steroid Biochem Mol Biol. 2013 Sep;137:107-23
references: 23435015
references: Biochim Biophys Acta. 2000 Mar 6;1474(1):1-4
references: 10699483
references: Endocrinology. 2008 Jul;149(7):3531-9
references: 18420743
references: J Histochem Cytochem. 2000 Jul;48(7):905-14
references: 10858267
references: Endocr Rev. 2000 Oct;21(5):457-87
references: 11041445
references: J Cell Biochem. 2011 Jun;112(6):1499-505
references: 21344493
references: Front Biosci. 2006 Sep 01;11:2230-48
references: 16720310
references: Br J Dermatol. 2013 Mar;168(3):595-601
references: 23363016